Richard A. Fair - 16 Aug 2021 Form 4/A - Amendment Insider Report for BELLICUM PHARMACEUTICALS, INC

Role
President and CEO, Director
Signature
/s/ Richard A. Fair
Issuer symbol
N/A
Transactions as of
16 Aug 2021
Net transactions value
$0
Form type
4/A - Amendment
Filing time
18 Aug 2021, 12:21:16 UTC
Date Of Original Report
16 Aug 2021
Previous filing
11 Jun 2021
Next filing
16 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BLCM Stock Option (right to buy) Award $0 +265,000 $0.000000 265,000 16 Aug 2021 Common Stock 265,000 $2.88 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amendment is being filed to correct the typographical error in the exercise price of the stock option on the original Form 4 filed with the SEC on August 16, 2021